Cytek Investor Presentation Deck slide image

Cytek Investor Presentation Deck

Cytek Technology Enables Applications. Total Peer Reviewed Scientific Publication by Application 9% 5% 4% 12% 2% 12% 2% 2% 21% 13% 13% ■Infectious disease. ■ Immunology Immunotherapy ■COVID-19 ■ Oncology Immuno-oncology ■ Inflammation ■ Neurobiology Drug discovery ■Auto-immune disorder ■ Genomics Transplantation ■ Viral infection Cell # Publications 3 Q3 '18 Cancer Research 6 Q4 '18 9 AAGR 11 Q1 '19 Q2 '19 JCI INSIGHT 18 Q3 '19 me pc HC- que pofsit 25 Q4 '19 45 Q1 20 70 The Journal Immunology 111 172 242 Q2 '20 Q3 '20 Q4 '20 Q1 '21 nature INSIDE GREEN FLUORESCENT PROTEIN 325 414 Q2 '21 Q3 '21 516 Q4 '21 Science Advances AAAAS 652 Q1 22 768 881 Q2 '22 Q3'22 7
View entire presentation